INSIGHTS ON DRUG DEVELOPMENT
-
![GettyImages-1185624320-scientist-lab-smiling]( "Selecting A CDMO For Custom Activated PEGs")
Selecting A CDMO For Custom Activated PEGsCustom-activated PEGs require thoughtful planning and precise analytical control. Discover key considerations for selecting a partner capable of supporting scalable, compliant PEGylation.
-
![GettyImages-2036497698 clinical lab]( "Molecular Properties Of PROTACs And The Relationship To Formulation Design")
Molecular Properties Of PROTACs And The Relationship To Formulation DesignHere, we conduct a comprehensive analysis of diverse PROTAC (Proteolysis Targeting Chimeras) structures, evaluating their calculated physicochemical properties to identify key trends.
-
![Christine Webinar Archive]( "Key Metrics In Antibody Drug Development")
Key Metrics In Antibody Drug DevelopmentExplore key techniques like DSC and Rheology to assess thermal stability and viscosity in antibody drug development. Gain practical insights to enhance biologic candidate selection, formulation, and delivery.
-
![icellis family]( "Streamline Your Workflow With An Innovative Fixed-Bed System")
Streamline Your Workflow With An Innovative Fixed-Bed SystemDiscover how an innovative fixed-bed system streamlines workflows and supports consistent, high-yield manufacturing across a range of applications.
-
White Paper: Nasal Delivery Of Spray Dried Biologics: Opportunities And Challenges10/16/2024
Explore the potential of spray-dried nasal formulations for biologics to achieve excellent stability and targeted delivery, paving the way for innovative and effective therapeutic solutions.
-
Advances In Custom Medium Development: The Multi-Omics Difference6/9/2025
Spent media analysis continues to be an essential part of many media development workflows. Newer techniques, however, using state-of-the-art analytical technology, are becoming more popular.
-
From 51% Yield To 87% With Targeted Impurity Removal5/7/2026
Targeted impurity identification and purification redesign dramatically improved yield, reduced process complexity, and enabled reliable API supply for Phase II clinical development.
-
How To Confidently Predict Toxicity Of Preclinical Drug Candidates8/2/2024
Incorporating Liver-Chips into preclinical workflows could reduce drug-induced liver injury-related trial failures. Review this quantitative framework for integrating Liver-Chip data into pharmaceutical decision-making.
-
Optimize Your RNA-LNP Delivery With Ionizable Lipids4/3/2025
Ionizable lipids play a crucial role in optimizing LNP delivery. Discover how lipid nanoparticles revolutionize intracellular drug delivery to enhance RNA vaccines, cell therapies, protein replacement, and gene editing.
DRUG DEVELOPMENT SOLUTIONS
-
![micronization]( "Small Scale, R&D Micronization Equipment")
The systems can be provided in sterile, toxic or sterile toxic arrangements with the great advantage of being 100 % scalable.
-
MaxPeak™ Premier Columns utilize MaxPeak High Performance Surfaces that are designed to increase analyte recovery, sensitivity, and reproducibility by minimizing analyte/surface interactions that can lead to sample losses.
-
![Scientist standing with SpectraMax iD5e mutlt-mode microplate reader gas mixer included]( "SpectraMax iD3s And iD5e Multi-Mode Microplate Readers")
Designed for today’s assays and tomorrow’s breakthroughs—flexible detection that evolves with your science.
The SpectraMax® iD3s and iD5e Multi-Mode Microplate Readers deliver flexible, scalable solutions for absorbance, fluorescence, and luminescence assays—with advanced capabilities for evolving research needs. The iD3s reader offers a streamlined, affordable platform with a tunable monochromator and temperature control, while the iD5e reader adds enhanced detection modes including time-resolved fluorescence (TRF) and tunable fluorescence polarization (FP) and can be expanded to include TR-FRET, HTRF, BRET and western blot. Both readers support on board fluidics with optional dual injectors.
-
![GettyImages-2178732166-scientists-screen-imaging-microscope-laboratory]( "Application Guide For Multimode Readers")
Explore imaging, fluorescence, and luminescence-based techniques for cell analysis, viability, and gene expression, as well as how multimode readers streamline workflows and enhance data quality.
-
![Scientist Using Tablet In Lab GettyImages-1354172577]( "PBPK Predictive Modeling Services")
Early identification of potential absorption risks is critical for rapid and efficient drug development. Lonza's PBPK modeling services are designed to de-risk your drug development program.
